henhaobio
Sign in

medRxivGenetic & Genomic MedicinePreprint

PrimateAI-3D outperforms AlphaMissense in real-world cohorts

David A. ParryiD, Tom Bosc, Tobias Hamp, Petko P. FizieviD, Abhishek SharmaiD, Irfahan KassamiD, Jeremy F. McRaeiD, Kyle Kai‐How FarhiD

PDFDOI

Abstract

Accurately predicting the impact of genetic variants is essential for interpreting genomic data, yet no consensus exists on how to measure classifier performance. We prepared the most comprehensive set of benchmarks to date and applied them to the recently published models PrimateAI-3D and AlphaMissense. PrimateAI-3D outperforms AlphaMissense on rare-disease cohort and biobank benchmarks, indicating that performance on clinical databases or in vitro assays does not reliably generalize to real-world cohorts.

Citations
5

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.